关键字不能为空!

Enter

Home » Patient Care » Departments & Services » Clinical Departments » Breast Surgery

Wang Shu,M.D.

DEPARTMENT OF Breast Surgery

Wang Shu,M.D.
  • Department:Breast Surgery
  • Gender:female
  • Title:Director of breast disease center; Professor of General Surgery
Professional Highlights

 

Director of breast disease center
2002-2010 Chinese Society of Clinical Oncology 

Fellowship & Certification
General Surgery, Peking University People’s Hospital, Peking, PRC
Visiting Doctor,M.D. Anderson Cancer Center, Houston, TX ,USA
Postdoctoral Program,UMASS Memorial Cancer Center, Worcester, MA, USA

Interests

Clinical Interests
Early diagnosis, modality treatment strategies; neoadjuvant chemotherapy, neoadjuvant endocrinotherapy;
Breast conservation; sentinel lymph node biopsy; skin-sparing mastectomy; breast reconstruction
Research Interests
MAPK signal transduction, Estrogen receptor subtypes, Prognostic factors of breast carcinoma; predictor of the sensitivity of neoadjuvant chemotherapy; gene profiles; proteomics 

Research & Publications

1. J Xie1, R Litman1, S Wang1, et al.(1,co-first author)Targeting the FANCJ-BRCA1 interation promotes a switch from recombination to poleta-dependent bypass. Oncogene.2010
2. Wang Shu, Guo Jiajia, Yang Houpu,et al.Screening of sensitive and resistant related proteins in neo-adjuvant chemotherapy of breast cancer by protein microarray. Zhonghua Wai Ke Za Zhi(Chinese Journal of Surgery). 2010
3.Shu wang, Houpu Yang, Hongjun Liu et al. Response to neoadjuvant therapy and disease free sruvival in patients with triple-negative breast cancer. Japanese Journal of cancer and chemotherapy. 2009
4. Cao Yingming, Wang Shu, Zhang Jiaqing et al. MEK inhibitor improves the epirubicin sensitivity of breast carcinoma cell line MCF-7. Zhongguo Ai Zheng Za Zhi.(China Oncology)2008.
5.Wang Shu, Zhang Jiaqing, Qiao Xinmin etal. Histopathologic changes of breast cancer following neoadjuvant chemotherapy in locally advanced breast cancer. Zhongguo Fu Chan Ke Lin Chuang Za Zhi(Chinese Journal of Clinical Obstetrics and Gynecology),2007
6.Shu Wang, Jiaqing Zhang, Xinmin Qiao, Deqi Yang, Fuzhong Tong, Hongjun Liu. The effect of neo-adjuvant chemotherapy on estrogen and progesterone receptor expression in breast Carcinoma. Zhonghua Wai Ke Za Zhi(Chinese Journal of Surgery). 2005.
7.Shu Wang, Shan Wang, Jiaqing Zhang, Xinmin Qiao, Deqi Yang, Fuzhong Tong, Yingjiang Ye, Zhirong Cui. Expression and significance of ERα and ERβ in the Development of Human Breast Carcinoma. Zhonghua Wai Ke Za Zhi (Chinese Journal of Surgery), 2004.
8.Shu Wang, Jiaqing Zhang, Xinmin Qiao, Deqi Yang, Fuzhong Tong. An Analysis of Estrogen Receptor Subtypes and Her-2 Expression in Human Breast Carcinoma Zhongguo Fu Chan Ke Lin Chuang Za Zhi(Chinese Journal of Clinical Obstetrics and Gynecology),2004.
9.Shu Wang, Shan Wang, Xueguang Zhu, Jiaqing Zhang, Xinmin Qiao, Yingjiang Ye, Bin Liang, Xiangtao Ma, Zhirong Cui. Significance of MEK-ERK cascade in the development of human breast carcinoma. Zhonghua Wai Ke Za Zhi (Chinese Journal of Surgery), 2002.
10.Miao Liu, Fuzhong Tong, Shu Wang, Hongjun Liu, Jiao Li, Deqi Yang, Xinmin Qiao, Jiaqing Zhang. Correlation of hormone receptors expression and response to neoadjuvant chemotherapy in breast cancer. Zhongguo Fu Chan Ke Lin Chuang Za Zhi (Chinese Journal of Clinical Obstetrics and Gynecology),2005.
11.Deqi Yang, Shan Wang, Shu Wang, Yingjiang Ye, Zhirong Cui. Effect of MAPK signal transduction in the non-estrogen antagonistic mechanism of tamoxifen. Zhonghua Yi Xue Za Zhi(Chinese Medical Journal), 2002.
12.Fuzhong Tong, Hongjun Liu, Shu Wang, Deqi Yang, Jin Gu, Xinmin Qiao, Jiaqing Zhang. Clinical evaluation of effects and improvement in quality of life from palliative therapy of combination chemotherapy with Furtulon and consecutive low-dose cisplatin in cases of unresectable advanced gastrointestinal carcinoma. Gan To Kagaku Ryoho (Cancer and chemotherapy), 2001.
13.Xinmin Qiao, Fenghua Zhang, Shu Wang, Lin Cheng, Jiaqing Zhang. Prognostic significance of serum CA15-3 detection in patients with breat carcinoma. Zhonghua Pu Tong Wai Ke Za Zhi(Chinese Journal of General Surgery),2004.
14.Jiaqing Zhang, Shu Wang. Endocrinotherapy of breast carcinoma. Shi Yong Lin Chuang Yi Yao Za Zhi(Journal of Clinical Medicine in Practice), 2003. review.
15.Jiaqing Zhang, Shu Wang. Progress and future of new techniques in surgery for breast. Zhongguo Pu Wai Ji Chu Yu Lin Chuang Za Zhi(Chinese Journal of Bases and Clinics in Gerneral Surgery),2005.review.
16.Jiaqing Zhang, Shu Wang, Xinmin Qiao. Present status and prospects of breast carcinoma. Zhonghua Wai Ke Za Zhi(Chinese Journal of Surgery).2002. review.
17.Jiaqing Zhang, Xinmin Qiao, Shu Wang. Indication for endocrinotherapy of breast carcinoma. Lin Chuang Wai Ke Za Zhi(Journal of Clinical Surgery), 2000.review.
18.Jiaqing Zhang, Xinmin Qiao, Fuzhong Tong, Shu Wang. Adjuvant endocrinotherapy in breast carcinoma. Zhonghua Zhong Liu Za Zhi(Chinese Journal of Oncology),1999. review.